Immunometabolic inflammation and hepatocellular carcinoma

作     者：Jia-Xi Mao Fei Teng Cong Liu Hang Yuan Jia-Yong Dong Hong Fu Guo-Shan Ding Wen-Yuan Guo 

作者机构：Department of Liver Surgery and Organ Transplantation Changzheng Hospital Naval Medical University 

出 版 物：《Hepatobiliary & Pancreatic Diseases International》 (国际肝胆胰疾病杂志（英文版）)

年 卷 期：2019年第18卷第3期

页      面：298-300页

核心收录：

学科分类：10[医学] 

基　　金：supported by grants from the National Nat-ural Science Foundation of China(81702923) the Foundation of Shanghai Science and Technology Commission(15411950403,18ZR1439300) the Foundation of Shanghai Municipal Health Com-mission(20174Y0171) the Precision Medicine Project of Naval Medical University,China(2017JZ50) Outstanding Postgradu-ate Seedling Cultivation Fund of Naval Medical University 

主　　题：Editor transformation progression 

摘      要：To the Editor: Inflammation-cancer transformation and metabolomics are hot topics in hepatocellular carcinoma (HCC). Cancer-related inflammation and anti-cancer immunity co-exist in cancer progression and the microenvironmental conditions dictate the direction [1].